Signild Asberg

Summary

Affiliation: Uppsala University
Country: Sweden

Publications

  1. ncbi request reprint Warfarin-associated intracerebral hemorrhage after ischemic stroke
    Signild Asberg
    From the Department of Medical Sciences, Uppsala University, Uppsala, Sweden S Å, K M H, A T Department of Statistics, Umea University, Umea, Sweden M E and AstraZeneca R and D, Molndal, Sweden K M H
    Stroke 45:2118-20. 2014
  2. doi request reprint Ischemic stroke and secondary prevention in clinical practice: a cohort study of 14,529 patients in the Swedish Stroke Register
    Signild Asberg
    Department of Medical Sciences, Uppsala University Hospital, Uppsala, Sweden
    Stroke 41:1338-42. 2010
  3. doi request reprint Hemorrhage after ischemic stroke - relation to age and previous hemorrhage in a nationwide cohort of 58,868 patients
    Signild Asberg
    Department of Medical Sciences, Uppsala University, Uppsala, Sweden
    Int J Stroke 8:80-6. 2013
  4. doi request reprint Comparison of cardiovascular risk factors and survival in patients with ischemic or hemorrhagic stroke
    Karin M Henriksson
    AstraZeneca, Epidemiology R and D, Molndal, Sweden
    Int J Stroke 7:276-81. 2012
  5. doi request reprint Reduced risk of death with warfarin - results of an observational nationwide study of 20 442 patients with atrial fibrillation and ischaemic stroke
    Signild Asberg
    Department of Medical Sciences, Uppsala University, Uppsala, Sweden
    Int J Stroke 8:689-95. 2013

Detail Information

Publications5

  1. ncbi request reprint Warfarin-associated intracerebral hemorrhage after ischemic stroke
    Signild Asberg
    From the Department of Medical Sciences, Uppsala University, Uppsala, Sweden S Å, K M H, A T Department of Statistics, Umea University, Umea, Sweden M E and AstraZeneca R and D, Molndal, Sweden K M H
    Stroke 45:2118-20. 2014
    ..The aim was to investigate the risk of intracerebral hemorrhage (ICH) in patients with ischemic stroke taking warfarin and whether this risk changed over time...
  2. doi request reprint Ischemic stroke and secondary prevention in clinical practice: a cohort study of 14,529 patients in the Swedish Stroke Register
    Signild Asberg
    Department of Medical Sciences, Uppsala University Hospital, Uppsala, Sweden
    Stroke 41:1338-42. 2010
    ..We studied the prescription of antiplatelet drugs, angiotensin-converting enzyme inhibitors, statins, and anticoagulant drugs and their relation to risk of death...
  3. doi request reprint Hemorrhage after ischemic stroke - relation to age and previous hemorrhage in a nationwide cohort of 58,868 patients
    Signild Asberg
    Department of Medical Sciences, Uppsala University, Uppsala, Sweden
    Int J Stroke 8:80-6. 2013
    ..In randomized controlled trials of secondary prevention after stroke, the risk of hemorrhage varies between 1% and 5% per year in patients with antithrombotic therapy, i.e. anticoagulants and antiplatelets...
  4. doi request reprint Comparison of cardiovascular risk factors and survival in patients with ischemic or hemorrhagic stroke
    Karin M Henriksson
    AstraZeneca, Epidemiology R and D, Molndal, Sweden
    Int J Stroke 7:276-81. 2012
    ..Differences in risk factor profiles between patients with ischemic and hemorrhagic stroke may have an impact on subsequent mortality...
  5. doi request reprint Reduced risk of death with warfarin - results of an observational nationwide study of 20 442 patients with atrial fibrillation and ischaemic stroke
    Signild Asberg
    Department of Medical Sciences, Uppsala University, Uppsala, Sweden
    Int J Stroke 8:689-95. 2013
    ..Our aim was to investigate this relationship in a large cohort of unselected patients with atrial fibrillation and ischaemic stroke...